Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Costas Tsatalas
Hydroxyurea (HU) Is Effective in Reducing JAK2V617F Mutated Clone Size in the Peripheral Blood of Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Patients
Annals of Hematology
Medicine
Hematology
Related publications
A Higher JAK2 V617f-Mutated Clone Is Observed in Platelets Than in Granulocytes From Essential Thrombocythemia Patients, but Not in Patients With Polycythemia Vera and Primary Myelofibrosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Updates in the Management of Polycythemia Vera and Essential Thrombocythemia
Therapeutic Advances in Hematology
Hematology
Clonal Analyses Reveal Associations of JAK2V617F Homozygosity With Hematologic Features, Age and Gender in Polycythemia Vera and Essential Thrombocythemia
Haematologica
Hematology
Changes in Peripheral Blood Lymphocytes in Polycythemia Vera and Essential Thrombocythemia Patients Treated With Pegylated-Interferon Alpha and Correlation With JAK2 V617F Allelic Burden
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Polycythemia Vera (PV)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Hydroxyurea Induced Oscillations in Twelve Patients With Polycythemia Vera
Haematologica
Hematology
Erythromelalgic Thrombotic Thrombocythemia (ETT) and Hemorrhagic Trombocythemia (HT) in Patients With Essential Thrombocythaemia (ET) and Polycythaemia Vera (PV)
Journal of Hematology & Thromboembolic Diseases
Myocardial Infarction as a Thrombotic Complication of Essential Thrombocythemia and Polycythemia Vera
Anatolian journal of cardiology
Cardiovascular Medicine
Cardiology
Polycythemia Vera and Essential Thrombocythemia: 2019 Update on Diagnosis, Risk-Stratification and Management
American Journal of Hematology
Hematology
